Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > British Thyroid Foundation joins pioneering Connect Immune Research partnership
The patient support charity British Thyroid Foundation has joined the group of organisations collaborating on research into the causes of autoimmune conditions.
Autoimmune conditions occur when the body’s immune system begins attacking its own cells. Often, people have more than one autoimmune condition, fuelling the idea that there are common underlying biological mechanisms across different autoimmune conditions.
Connect Immune Research is a ground-breaking initiative launched in 2018 by JDRF, the MS Society, Versus Arthritis and the British Society for Immunology. It brings together organisations that research autoimmune conditions to understand how autoimmune disorders are linked.
The British Thyroid Foundation (BTF) committing to the project now is testament to how the autoimmune research community views this pivotal partnership. Scientists coming together from different fields broadens the scope of research, leading to faster and more innovative outcomes. Connect Immune Research now has even more experts working collaboratively. This accelerates its mission to find the root causes of autoimmunity and develop treatments for people living with autoimmune conditions.
Julia Priestley, CEO (Development) of the BTF, said: “We are delighted to join Connect Immune Research, which is such an important network of organisations with common interests. We look forward to working together and sharing resources to encourage much-needed research in this area.”
The BTF is a patient support organisation dedicated to helping people live better with thyroid disease by providing evidence-based information and a support network. BTF funds vital research into thyroid disease to improve understanding, diagnosis and treatment of thyroid disorders.
Professor Marian Ludgate from the Thyroid Research Group at Cardiff University School of Medicine said: “Autoimmune thyroid diseases, such as Hashimoto’s thyroiditis and Graves’ disease, are the most commonly occurring autoimmune diseases. They affect millions of people of all ages in the UK. Unfortunately, even though the prevalence of thyroid autoimmunity is increasing, treatments for most patients haven’t changed in decades.”
Now the British Thyroid Foundation have joined the collaboration, Connect Immune Research is made up of the following organisations:
Rachel Connor, Director of Research Partnerships at JDRF, said: “We know that there are many people who live with more than one autoimmune condition, and many more people who have family members who are affected by other autoimmune conditions. So, it makes sense to investigate what these conditions have in common. The more autoimmune conditions we have represented in the Connect Immune Research partnership, the more we can ensure this research fits the needs of everyone affected by autoimmunity.”
The first person to receive a new stem cell-derived therapy for type 1 diabetes, VX-880, has been found to need 91% less daily insulin 90 days after receiving just half the target dose.
An historic deal has been agreed between JDRF International and partners, to deliver lower-cost insulin across the USA from 2024 to everyone – regardless of insurance status.
We’re delighted to announce that we’re going to be working together with DigiBete to provide children, young people and their families with the information and support they need to live life well with type 1 diabetes.
In a project funded by JDRF, scientists have turned on a gene in cells from a person with type 1 diabetes that allows them to produce insulin again.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.